Security key
63009J107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 985
- Total 13F value
- $37,135
- Share change
- +157
- SEC-reported price per share
- $37.70
- Number of holders
- 1
- Value change
- +$5,919
- Number of buys
- 1
- Shares outstanding
- 46,821,220
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
NBTX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63009J107
Recent filing periods:
Ownership snapshot
Top reported holders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
JOHNSON & JOHNSON
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 8.9%
13D/G row: Invus Global Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Invus Global Management, LLC leads the comparable SEC ownership view at 8.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership
Top 5
Invus Global Management, LLC
8.9%
BAILLIE GIFFORD & CO
4.1%
JOHNSON & JOHNSON
12%
MORGAN STANLEY
0.08%
Optiver Holding B.V.
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
Invus Public Equities, L.P.
|
8.9%
|
$13,545,053
4,232,829 shares
|
$0 | 31 Dec 2023 |
| BAILLIE GIFFORD & CO |
13D/G
|
4.1%
|
$6,142,944
1,919,670 shares
|
$0 | 31 Dec 2024 |
| JOHNSON & JOHNSON |
13F
Company
|
12%
|
$173,607,200
5,623,816 shares
|
— | 31 Mar 2026 |
| MORGAN STANLEY |
13F
Company
|
0.08%
|
$1,119,778
36,274 shares
|
— | 31 Mar 2026 |
| Optiver Holding B.V. |
13F
Company
|
0.03%
|
$416,776
13,501 shares
|
— | 31 Mar 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
0.02%
|
$285,207
9,239 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
985
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
15
Q2 2026 holders
1
Holder diff
-14
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend